Soluble Urokinase Plasminogen Activator Receptor as a Diagnostic and Prognostic Biomarker in Cardiac Disease

This review summarizes the published literature referring to the use and validity of the biomarker soluble urokinase plasminogen activator receptor (suPAR) when used for the assessment of patients with cardiac diseases. It is measured by enzyme-linked immunosorbent assay (ELISA) in plasma samples. I...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Med Res
Asıl Yazarlar: Velissaris, Dimitrios, Zareifopoulos, Nicholas, Koniari, Ioanna, Karamouzos, Vasilios, Bousis, Dimitris, Gerakaris, Andreas, Platanaki, Christina, Kounis, Nicholas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elmer Press 2021
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8016523/
https://ncbi.nlm.nih.gov/pubmed/33854652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr4459
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller